Subscribe to RSS

DOI: 10.1055/a-2681-2538
Transoral incisionless fundoplication for patients with gastroesophageal reflux disease after peroral endoscopic myotomy: Prospective cohort
Clinical Trial: Registration number (trial ID): 81178623.0.0000.0068, Trial registry: Brazilian Clinical Trials Registry (http://www.ensaiosclinicos.gov.br/), Type of Study: Prospective
Abstract
Background and study aims
Achalasia is a condition related to failure of relaxation of the lower esophageal sphincter (LES). Treatment is based on reducing LES pressure. Although treatment is traditionally surgical, poor candidates for this modality may be treated with peroral endoscopic myotomy (POEM). However, POEM is associated with a relatively high incidence of gastroesophageal reflux disease (GERD). For cases refractory to proton pump inhibitors (PPIs), transoral incisionless fundoplication (TIF) is one of the endoscopic therapies proposed.
Patients and methods
This was a pilot single-center prospective cohort study including 10 patients with post-POEM GERD refractory to clinical management who underwent endoscopic treatment with the TIF procedure between February and November 2021. We included patients ≥ 18 years old who developed GERD after POEM.
Results
Technical success was achieved in all 10 cases treated with TIF. In 6- and 12-month follow-up, seven patients (70%) reduced PPI use. Two patients (20%) had no esophagitis initially, increasing to five (55%) at 6 months and four (44%) at 12 months. Symptom evaluation and GERD-HRQL questionnaire showed a significant score reduction at 6 months and a downward trend at 12 months. Mean Eckardt score showed a decreasing trend, although mean dysphagia score showed a slight tendency to increase in 1 year. The procedure was considered safe, with no adverse events.
Conclusions
Use of TIF seems to be a feasible alternative for treating GERD after POEM, improving both clinical and endoscopic parameters and pHmetry in a considerable percentage of cases.
Publication History
Received: 19 September 2024
Accepted after revision: 24 July 2025
Accepted Manuscript online:
11 August 2025
Article published online:
01 September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Eduardo Guimarães Hourneaux de Moura, Matheus Ferreira de Carvalho, Victor Lira de Oliveira, Mateus Bond Boghossian, Antonio Afonso Miranda Neto, Eduardo Turiani Hourneaux de Moura, André Orsini Ardengh, Ary Nasi, Kenneth Chang, Mateus Pereira Funari. Transoral incisionless fundoplication for patients with gastroesophageal reflux disease after peroral endoscopic myotomy: Prospective cohort. Endosc Int Open 2025; 13: a26812538.
DOI: 10.1055/a-2681-2538
-
References
- 1
Hasan A,
Low EE,
Fehmi SA.
et al.
Evolution and evidence-based adaptations in techniques for peroral endoscopic myotomy
for achalasia. Gastrointest Endosc 2022; 96: 189-196
MissingFormLabel
- 2
Repici A,
Fuccio L,
Maselli R.
et al.
GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication:
a systematic review with meta-analysis. Gastrointest Endosc 2018; 87: 934-943 e18
MissingFormLabel
- 3
Tassi V,
Lugaresi M,
Pilotti V.
et al.
Outcomes of Heller myotomy for esophageal achalasia: Lessons from a 48-year prospective
experience with 4 different techniques. Ann Surg 2023; 278: e27-e34
MissingFormLabel
- 4
Conte TM,
Haddad LB de P,
Ribeiro IB.
et al.
Peroral endoscopic myotomy (POEM) is more cost-effective than laparoscopic Heller
myotomy in the short term for achalasia: economic evaluation from a randomized controlled
trial. Endosc Int Open 2020; 8: E1673-E1680
MissingFormLabel
- 5
Ujiki MB,
VanDruff VN.
Peroral endoscopic myotomy for achalasia. World J Surg 2022; 46: 1542-1546
MissingFormLabel
- 6
Kum AS-T,
De Moura DTH,
Proença IM.
et al.
Gastroesophageal reflux waning over time in endoscopic versus surgical myotomy for
the treatment of achalasia: A systematic review and meta-analysis. Cureus 2022; 14:
e31756
MissingFormLabel
- 7
de Moura ETH,
Jukemura J,
Ribeiro IB.
et al.
Peroral endoscopic myotomy vs laparoscopic myotomy and partial fundoplication for
esophageal achalasia: A single-center randomized controlled trial. World J Gastroenterol
2022; 28: 4875-4889
MissingFormLabel
- 8
Martins RK,
Ribeiro IB,
de Moura DTH.
et al.
Peroral (POEM) or surgical myotomy for the treatment of achalasia: a systematic review
and meta-analysis. Arq Gastroenterol 2020; 57: 79-86
MissingFormLabel
- 9
Mota RCL,
de Moura EGH,
de Moura DTH.
et al.
Risk factors for gastroesophageal reflux after POEM for achalasia: a systematic review
and meta-analysis. Surg Endosc 2021; 35: 383-397
MissingFormLabel
- 10
Zhang H,
Zeng X,
Huang S.
et al.
Mid-term and long-term outcomes of peroral endoscopic myotomy for the treatment of
achalasia: A systematic review and meta-analysis. Dig Dis Sci 2023; 68: 1386-1396
MissingFormLabel
- 11
Teh JL,
Tham HY,
Soh AY.
et al.
Gastro-esophageal reflux disease (GERD) after peroral endoscopic myotomy (POEM). Surg
Endosc 2022; 36: 3308-3316
MissingFormLabel
- 12
Zaninotto G,
Rizzetto C,
Zambon P.
et al.
Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J
Surg 2008; 95: 1488-1494
MissingFormLabel
- 13
Nagi TK,
Suarez ZK,
Haider MA.
et al.
Per-oral endoscopic myotomy-induced gastroesophageal reflux disease and review of
the efficacy of proton pump inhibitors as a management strategy: Review of the literature.
Cureus 2023; 15: E50324
MissingFormLabel
- 14
Inoue H,
Shiwaku H,
Kobayashi Y.
et al.
Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from
an international multicenter experience. Esophagus 2020; 17: 3-10
MissingFormLabel
- 15
Perbtani YB,
Westerveld DR,
Yang DJ.
et al.
CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after
per-oral endoscopic myotomy (POEM). Endosc Int Open 2021; 9: E843-E847
MissingFormLabel
- 16
Nurczyk K,
Farrell TM,
Patti MG.
Antireflux surgery for gastroesophageal reflux refractory to medical treatment after
peroral endoscopic myotomy. J Laparoendosc Adv Surg Tech A 2020; 30: 612-614
MissingFormLabel
- 17
Richardson WS,
Gorham JK,
Neal N.
et al.
Endoscopic treatment of gastroesophageal reflux disease. Adv Surg 2022; 56: 205-227
MissingFormLabel
- 18
Trad KS,
Barnes WE,
Prevou ER.
et al.
The TEMPO Trial at 5 years: Transoral fundoplication (tif 2.0) is safe, durable, and
cost-effective. Surg Innov 2018; 25: 149-157
MissingFormLabel
- 19
Haseeb M,
Brown JRG,
Hayat U.
et al.
Impact of second-generation transoral incisionless fundoplication on atypical GERD
symptoms: a systematic review and meta-analysis. Gastrointest Endosc 2023; 97: 394-406
e2
MissingFormLabel
- 20
Zhu X,
Shen J.
Anti-reflux mucosectomy (ARMS) for refractory gastroesophageal reflux disease. Eur
J Med Res 2024; 29: 185
MissingFormLabel
- 21
Shimamura Y,
Inoue H,
Tanabe M.
et al.
Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease:
An international bi-institutional study. J Gastroenterol Hepatol 2024; 39: 149-156
MissingFormLabel
- 22
Gyawali CP,
Kahrilas PJ,
Savarino E.
et al.
Modern diagnosis of GERD: the Lyon Consensus. Gut 2018; 67: 1351-1362
MissingFormLabel
- 23
Velanovich V.
The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 2007;
20: 130-134
MissingFormLabel
- 24
Eckardt VF,
Aignherr C,
Bernhard G.
Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology
1995; 108: 1308-1315
MissingFormLabel
- 25
Tyberg A,
Choi A,
Gaidhane M.
et al.
Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a
crucial addition to our arsenal. Endosc Int Open 2018; 6: E549-E552
MissingFormLabel
- 26
Brewer Gutierrez OI,
Chang KJ,
Benias PC.
et al.
Is transoral incisionless fundoplication (TIF) an answer to post-peroral endoscopic
myotomy gastroesophageal reflux? A multicenter retrospective study. Endoscopy 2022;
54: 305-309
MissingFormLabel
- 27
DeWitt JM,
Al-Haddad M,
Stainko S.
et al.
Transoral incisionless fundoplication with or without hiatal hernia repair for gastroesophageal
reflux disease after peroral endoscopic myotomy. Endosc Int Open 2024; 12: E43-E49
MissingFormLabel
- 28
Trad KS,
Barnes WE,
Simoni G.
et al.
Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial
responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical
Trial. Surg Innov 2015; 22: 26-40
MissingFormLabel
- 29
Ayoub F,
Keihanian T,
Zabad N.
et al.
The role of transoral incisionless fundoplication (TIF) in the management of gastroesophageal
reflux disease (GERD) following peroral endoscopic myotomy (POEM): A pilot, prospective,
patient-driven study. Saudi J Gastroenterol 2024; 30: 266-271
MissingFormLabel
- 30
Testoni PA,
Testoni S,
Distefano G.
et al.
Long-term outcomes of transoral incisionless fundoplication for gastro-esophageal
reflux disease: systematic-review and meta-analysis. Endosc Int Open 2021; 9: E239-E246
MissingFormLabel
- 31
Chimukangara M,
Jalilvand AD,
Melvin WS.
et al.
Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort
study. Surg Endosc 2019; 33: 1304-1309
MissingFormLabel
- 32
Farias GFA,
de Moura DTH,
de Moura ETH.
et al.
Peroral endoscopic myotomy (POEM): a comparative study between Chagasic and idiopathic
achalasia. Endosc Int Open 2020; 8: E506-E512
MissingFormLabel
- 33
Ponds FA,
Oors JM,
Smout AJPM.
et al.
Reflux symptoms and oesophageal acidification in treated achalasia patients are often
not reflux related. Gut 2021; 70: 30-39
MissingFormLabel
- 34
Frazzoni M,
Conigliaro R,
Manta R.
et al.
Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory
GERD. Aliment Pharmacol Ther 2011; 34: 67-75
MissingFormLabel
- 35
Jaruvongvanich VK,
Matar R,
Reisenauer J.
et al.
Hiatal hernia repair with transoral incisionless fundoplication versus Nissen fundoplication
for gastroesophageal reflux disease: A retrospective study. Endosc Int Open 2023;
11: E11-E18
MissingFormLabel